ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration

Journal: Journal of Clinical Investigation

Published: 2019-05-01

DOI: 10.1172/jci79990

Affiliations: 24

Authors: 32

Go to article
Institutions Share
Center for Interdisciplinary Research in Biology (CIRB), France 0.13
Division of Clinical and Metabolic Genetics, SickKids U of T, Canada 0.10
Sorbonne University, France 0.10
Fer à Moulin Institute (IFM), France 0.10
Team 7 : Sleep and Emotional Memory, IFM, France 0.09
Wavefront-Engineering Microscopy (Emiliani) Group, Neurophotonics Laboratory, France 0.09
College of Medicine, MUSC, United States of America (USA) 0.06
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan 0.06
Graduate School of Medicine / School of Medicine, Tohoku University, Japan 0.06
Greenwood Genetic Center (GGC), United States of America (USA) 0.06
Models of Malignant and Therapeutic Stem Cells, France 0.04
Infrastructure Nationale d'Ingénierie des Cellules Souches Pluripotentes et Cellules Différenciées (INGESTEM), France 0.04
Department of Obstetrics and Gynaecology, U of T, Canada 0.01
Prenatal Diagnosis and Medical Genetics, U of T, Canada 0.01
The Hospital for Sick Children (SickKids), U of T, Canada 0.01
AP-HP Hôpital Paul Brousse, France 0.01
Azm Center for the Research in Biotechnology and its Applications, LU, Lebanon 0.01
Faculty of Medicine, UPSud, France 0.01
Middle East Institute of Health (MEIH), Lebanon 0.01
University of Paris-Sud (UPSud), France 0.01